Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Schedule of Stock Awards Granted (Details)

v3.21.2
Stock-Based Compensation - Schedule of Stock Awards Granted (Details)
9 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Share-based Payment Arrangement [Abstract]  
Number of Shares, Outstanding, Beginning balance | shares 982,500
Number of Shares, Granted | shares 604,404
Number of Shares, Exercised | shares
Number of Shares, Forfeited | shares
Number of Shares, Outstanding, Ending balance | shares 1,586,904
Number of Shares, Exercisable, Ending balance | shares 383,418
Weighted Average Exercise Price, Outstanding, Beginning balance | $ / shares $ 0.1083
Weighted Average Exercise Price, Granted | $ / shares 2.1833
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Forfeited | $ / shares
Weighted Average Exercise Price, Outstanding, Ending balance | $ / shares 0.8986
Weighted Average Exercise Price, Exercisable, Ending balance | $ / shares $ 0.1895
Weighted Average Remaining Contractual Term (Years), Outstanding, Beigining balance 11 months 15 days
Weighted Average Remaining Contractual Term (Years), Outstanding, Ending balance 2 years 7 months 6 days
Weighted Average Remaining Contractual Term (Years), Exercisable, Ending balance 1 year 8 months 12 days
Aggregate Intrinsic Value, Outstanding, Beigining balance | $ $ 2,038,688
Aggregate Intrinsic Value, Outstanding, Ending balance | $ 2,038,688
Aggregate Intrinsic Value, Exercisable, Ending balance | $ $ 764,467